VIRBAC |
En tiempo real
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 367,5 EUR | -1,47 % |
|
+0,68 % | +2,23 % |
Resumen de negocios
- medicamentos para animales de compañía: fármacos para el control de plagas, vacunas, antibióticos, anestésicos, antiinflamatorios, productos para el cuidado bucodental, oftalmológicos y dermatológicos destinados a perros, gatos, caballos, aves, roedores, etc. El grupo también ofrece alimentos y chips de identificación electrónica;
- medicamentos para el ganado: medicamentos para el control de plagas y antibióticos destinados al ganado vacuno, ovino, porcino, aves de corral, etc.
Las ventas netas se distribuyen geográficamente de la siguiente manera: Francia (15,8%), Europa (24,9%), Asia (17,5%), América Latina (16,2%), América del Norte (13,3%), Pacífico (9,7%), África y Oriente Medio (2,6%).
Número de empleados: 5 459
Ventas por actividad
| EUR en millones | 2021 | Peso | 2022 | Peso | Delta |
|---|---|---|---|---|---|
Production Animals - Other Ruminants
16,8
%
| 172 | 16,2 % | 204 | 16,8 % | +18,56 % |
Pets- Specialties
10,9
%
| 112 | 10,5 % | 133 | 10,9 % | +19,10 % |
Pets - Parasiticides
10,1
%
| 108 | 10,2 % | 123 | 10,1 % | +13,38 % |
Pets - Others
10,1
%
| 101 | 9,5 % | 122 | 10,1 % | +20,85 % |
Pets - Antibiotics/Dermatology
9,1
%
| 101 | 9,5 % | 111 | 9,1 % | +9,61 % |
Pets - Specialized Food
8,1
%
| 78 | 7,4 % | 99 | 8,1 % | +25,64 % |
Production Animals - Bovine Antibiotics
7,1
%
| 81 | 7,6 % | 86 | 7,1 % | +6,04 % |
Pets - Immunology
7,0
%
| 77 | 7,2 % | 85 | 7,0 % | +10,79 % |
Production Animals - Bovine Parasiticides
6,2
%
| 58 | 5,4 % | 76 | 6,2 % | +31,77 % |
Production Animals - Aquaculture
3,6
%
| 48 | 4,5 % | 44 | 3,6 % | -6,93 % |
Production Animals - Other Pig/Poultry
3,0
%
| 33 | 3,1 % | 37 | 3,0 % | +9,28 % |
Pets - Equine
2,8
%
| 32 | 3,0 % | 34 | 2,8 % | +6,01 % |
Production Animals - Pig/Poultry Antibiotics
2,6
%
| 35 | 3,3 % | 32 | 2,6 % | -7,51 % |
Other
2,6
%
| 29 | 2,7 % | 32 | 2,6 % | +10,42 % |
Ventas por región
| EUR en millones | 2021 | Peso | 2022 | Peso | Delta |
|---|---|---|---|---|---|
Europe (excluding France)
24,9
%
| 281 | 26,4 % | 303 | 24,9 % | +7,75 % |
Asia
17,5
%
| 184 | 17,2 % | 213 | 17,5 % | +16,04 % |
Latin America
16,2
%
| 167 | 15,7 % | 197 | 16,2 % | +18,05 % |
France
15,8
%
| 185 | 17,4 % | 192 | 15,8 % | +3,85 % |
North America
13,3
%
| 124 | 11,7 % | 162 | 13,3 % | +30,38 % |
Pacific
9,7
%
| 94 | 8,9 % | 118 | 9,7 % | +24,75 % |
Africa & Middle East
2,7
%
| 30 | 2,8 % | 32 | 2,7 % | +9,33 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Sébastien Huron
CEO | Chief Executive Officer | 54 | 01/01/06 |
Habib Ramdani
DFI | Director of Finance/CFO | 48 | 01/02/16 |
Sophie Favini
COO | Chief Operating Officer | - | 01/07/23 |
| Chief Tech/Sci/R&D Officer | - | 01/05/94 | |
Sandrine Brunel
IRO | Public Communications Contact | - | 01/11/98 |
Michel Garaudet
IRC | Investor Relations Contact | 69 | 01/12/02 |
Marc Bistuer
PRN | Corporate Officer/Principal | 63 | 15/12/20 |
| Human Resources Officer | - | 01/05/15 | |
Nathalie Pollet
SAM | Sales & Marketing | - | 01/01/93 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
| Director/Board Member | 65 | 01/01/11 | |
Philippe Capron
BRD | Director/Board Member | 64 | 01/01/04 |
| Chairman | 59 | 01/01/98 | |
| Director/Board Member | 63 | 01/01/95 | |
| Director/Board Member | 53 | 18/06/19 | |
| Director/Board Member | 30 | 05/09/17 | |
Sylvie Gueguen
BRD | Director/Board Member | 59 | 30/10/18 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 8 458 000 | 4 193 415 ( 49,58 %) | 88 281 ( 1,044 %) | 49,58 % |
Participaciones
| Nombre | Acciones | % | Valoración |
|---|---|---|---|
VIRBAC 0.19% | 15 852 | 0.19% | 5 923 576 $ |
Información de la empresa
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
Bio Veto Tests SA
 Bio Veto Tests SA Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Bio Veto Tests SA is a French company that develops vaccines against viral and parasitic diseases in companion animals. The private company is based in Sanary sur Mer, France. Bio Veto Tests was acquired by Virbac SA on May 07, 2003. |
Pharmaceuticals: Major
|
Virbac Nutrition SAS
 Virbac Nutrition SAS Food: Specialty/CandyConsumer Non-Durables Part of Virbac SA, Virbac Nutrition SAS is a French company that manufactures and wholesales pet food. The private company is based in Vauvert, France. The company was founded in 1987. Philippe Domptail has been the CEO of the company since 2011. |
Food: Specialty/Candy
|
Virbac (Australia) Pty Ltd.
 Virbac (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac (Australia) Pty Ltd. is an Australian company that manufactures veterinary pharmaceuticals and vaccines. The private company is based in Milperra, Australia. |
Pharmaceuticals: Major
|
Virbac RSA (Pty) Ltd.
| |
Virbac Animal Health India Pvt Ltd.
| |
Virbac Ltd.
 Virbac Ltd. Medical DistributorsDistribution Services Part of Virbac SA, Virbac Ltd. is a British company that wholesales pharmaceutical products. The private company is based in Bury St. Edmunds, UK. Founded in 1986. |
Medical Distributors
|
Virbac New Zealand Ltd.
 Virbac New Zealand Ltd. Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac New Zealand Ltd. is a New Zealander company that manufactures medicines for animals. The private company is based in Auckland, New Zealand. |
Pharmaceuticals: Major
|
Virbac Mexico SA de CV
 Virbac Mexico SA de CV Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac Mexico SA de CV is a Mexican pharmaceutical company that manufactures pharmaceutical products. The private company is based in Guadalajara, Mexico. |
Pharmaceuticals: Major
|
Virbac Danmark A/S
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Ganancias trimestrales - Tasa de sorpresa
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +2,23 % | 3328,97 M | |
| -8,93 % | 6689,6 M | |
| +13,00 % | 3349,41 M | |
| +1,18 % | 1456,17 M | |
| -17,92 % | 1327,96 M | |
| -6,84 % | 1192,24 M | |
| -28,92 % | 1189,25 M | |
| -17,76 % | 1079,38 M | |
| -3,84 % | 1007,18 M | |
| -4,53 % | 868 M |
- Bolsa de valores
- Acciones
- Acción VIRP
- Empresa Virbac
